Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

CE-108, a new macrolide tetraene antibiotic

  • Francisco J. Pérez-Zúñiga
  • , Elena M. Seco
  • , T. Cuesta
  • , Falco Degenhardt
  • , Jorgen Rohr
  • , Carlos Vallín
  • , Yanelis Iznaga
  • , Marta E. Pérez
  • , Leonora González
  • , Francisco Malpartida

Producción científica: Articlerevisión exhaustiva

29 Citas (SciVal)

Resumen

In the search for strains producing antifungal compounds, a new tetraene macrolide CE-108 (3) has been isolated from culture broth of Streptomyces diastaticus 108. In addition, the strain also produces the previously described tetraene rimocidin (1) and also the aromatic polyketide oxytetracycline. Both tetraene compounds, structurally related, are produced in a ratio between 25 to 35%,(CE-108 compared to rimocidin), although it can be inverted toward CE-108 production by changing the composition of the fermentation medium. This paper deals with the characterization of the producer strain, fermentation, purification, structure determination and biological properties of the new macrolide tetraene CE-108.

Idioma originalEnglish
Páginas (desde-hasta)197-204
Número de páginas8
PublicaciónJournal of Antibiotics
Volumen57
N.º3
DOI
EstadoPublished - mar 2004

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Huella

Profundice en los temas de investigación de 'CE-108, a new macrolide tetraene antibiotic'. En conjunto forman una huella única.

Citar esto